JPH0354925B2 - - Google Patents

Info

Publication number
JPH0354925B2
JPH0354925B2 JP61170426A JP17042686A JPH0354925B2 JP H0354925 B2 JPH0354925 B2 JP H0354925B2 JP 61170426 A JP61170426 A JP 61170426A JP 17042686 A JP17042686 A JP 17042686A JP H0354925 B2 JPH0354925 B2 JP H0354925B2
Authority
JP
Japan
Prior art keywords
immune
bcg
ifn
day
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP61170426A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6327438A (ja
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to JP61170426A priority Critical patent/JPS6327438A/ja
Publication of JPS6327438A publication Critical patent/JPS6327438A/ja
Publication of JPH0354925B2 publication Critical patent/JPH0354925B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP61170426A 1986-07-18 1986-07-18 免疫強化皮内処方剤 Granted JPS6327438A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP61170426A JPS6327438A (ja) 1986-07-18 1986-07-18 免疫強化皮内処方剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP61170426A JPS6327438A (ja) 1986-07-18 1986-07-18 免疫強化皮内処方剤

Publications (2)

Publication Number Publication Date
JPS6327438A JPS6327438A (ja) 1988-02-05
JPH0354925B2 true JPH0354925B2 (enExample) 1991-08-21

Family

ID=15904696

Family Applications (1)

Application Number Title Priority Date Filing Date
JP61170426A Granted JPS6327438A (ja) 1986-07-18 1986-07-18 免疫強化皮内処方剤

Country Status (1)

Country Link
JP (1) JPS6327438A (enExample)

Also Published As

Publication number Publication date
JPS6327438A (ja) 1988-02-05

Similar Documents

Publication Publication Date Title
US5788964A (en) Method for sensitization of cancer cells for killer cell mediated lysis
CA2014130A1 (en) Use of pharmaceutical compositions containing at least one cytokine for the systemic treatment of preneoplastic lesions
CA2402169A1 (en) Formulation and method for treating neoplasms by inhalation
EP0433765A1 (en) The use of immunomodulants as synergistic agents of chemotherapeutics in tumor therapy
JP2007119493A (ja) γグロブリンの投与によるガン性疾患を処置するための免疫療法
Ariel Therapeutic effects of hydroxyurea. Experience with 118 patients with inoperable solid tumors
KR950008767B1 (ko) 에브셀렌(Ebselen)의 새로운 의약적 용도
Schmidberger et al. Granulocyte colony-stimulating factor treatment of leucopenia during fractionated radiotherapy
Harning et al. A treatment for metastasis of murine ocular melanoma.
EP1450850B1 (en) Method of administering a thymosin alpha 1 peptide
Garaci et al. Enhanced immune response and antitumor immunity with combinations of biological response modifiers
Droller Immunotherapy of metastatic renal cell carcinoma with polyinosinic-polycytidylic acid
Robertson et al. Tumor necrosis factor induces hemorrhagic necrosis of a sarcoma
JP2000507234A (ja) 遅延発症型嘔吐の治療薬の鼻内投与
CN111701012A (zh) Il-12在术后抗肿瘤方面的应用
US7439234B2 (en) Method for treating cancer patients undergoing chemotherapy
JPH0354925B2 (enExample)
Pitini et al. Spontaneous rupture of spleen during periferal blood stem cell mobilization in a patient with breast cancer
RU2110995C1 (ru) Способ коррекции побочных эффектов химиолучевой терапии
Stephens et al. Treatment of advanced cancer of the lower lip—the use of intraarterial or intravenous chemotherapy as basal treatment
JP4156028B2 (ja) 進行癌の処置のためのテモゾロミドとα−ＩＦＮの組合せ
Plengvanit et al. TREATMENT OF PRIMARY CARCINOMA OF THE LIVER WITH NITROGEN MUSTARD AND PREDNISOLONE.
RU2026679C1 (ru) Способ противоопухолевой терапии при первичном раке печени
Berek et al. Intraperitoneal immunotherapy of human ovarian carcinoma with recombinant interferon: A Phase I toxicity/immunopharmacology study
JP2999539B2 (ja) 白血球減少症の予防・治療剤